The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AQUINOX PHARMACEUTICALS INC | COM | 03842B101 | 10,525 | 747,500 | SH | OTR | 747,500 | 0 | 0 | ||
| AVEXIS INC | COM | 05366U100 | 111,222 | 900,000 | SH | OTR | 900,000 | 0 | 0 | ||
| BEIGENE LTD | SPONSORED ADR | 07725L102 | 105,840 | 630,000 | SH | OTR | 630,000 | 0 | 0 | ||
| BELLEROPON THERAPEUTICS INC | COM | 078771102 | 3,863 | 1,857,143 | SH | OTR | 1,857,143 | 0 | 0 | ||
| BELLICUM PHARMACEUTICALS INC | COM | 079481107 | 2,296 | 350,000 | SH | OTR | 350,000 | 0 | 0 | ||
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 22,925 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 35,242 | 2,712,986 | SH | OTR | 2,712,986 | 0 | 0 | ||
| DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 23,531 | 1,020,000 | SH | OTR | 1,020,000 | 0 | 0 | ||
| DERMIRA INC | COM | 24983L104 | 3,995 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
| ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 65,097 | 900,000 | SH | OTR | 900,000 | 0 | 0 | ||
| G1 THERAPEUTICS INC | COM | 3621LQ109 | 24,453 | 660,000 | SH | OTR | 660,000 | 0 | 0 | ||
| GTX INC DEL | COM NEW | 40052B207 | 28,223 | 1,590,000 | SH | OTR | 1,590,000 | 0 | 0 | ||
| IONIS PHARMACEUTICALS INC | COM | 462222100 | 13,753 | 312,000 | SH | OTR | 312,000 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 15,840 | 844,789 | SH | OTR | 844,789 | 0 | 0 | ||
| LA JOLLA PHARMACEUTICAL CO | COM PAR $.0001 2 | 503459604 | 7,966 | 267,500 | SH | OTR | 267,500 | 0 | 0 | ||
| LOXO ONCOLOGY INC | COM | 548862101 | 46,148 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
| MACROGENICS INC | COM | 556099109 | 55,352 | 2,200,000 | SH | OTR | 2,200,000 | 0 | 0 | ||
| MEDICINES COMPANY | COM | 584688105 | 41,175 | 1,250,000 | SH | OTR | 1,250,000 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 42,136 | 1,372,510 | SH | OTR | 1,372,510 | 0 | 0 | ||
| ODONATE THERAPEUTICS INC | COM | 676079106 | 59,875 | 2,826,938 | SH | OTR | 2,826,938 | 0 | 0 | ||
| ONCONOVA THERAPEUTICS INC | *W EXP 07/11/202 | 68232V116 | 72 | 241,644 | SH | OTR | 241,644 | 0 | 0 | ||
| NOVUS THERAPEUTICS INC | COM | 67011N105 | 1,635 | 324,383 | SH | OTR | 324,383 | 0 | 0 | ||
| PTC THERAPEUTICS INC | COM | 69366J200 | 70,174 | 2,600,000 | SH | OTR | 2,600,000 | 0 | 0 | ||
| REATA PHARMACEUTICALS INC | CL A | 75615P103 | 6,666 | 325,000 | SH | OTR | 325,000 | 0 | 0 | ||
| REGULUS THERAPEUTICS INC | COM | 75915K101 | 1,222 | 1,697,802 | SH | OTR | 1,697,802 | 0 | 0 | ||
| RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 18,196 | 5,140,000 | SH | OTR | 5,140,000 | 0 | 0 | ||
| RIGEL PHARMACEUTICALS INC | CALL | 766559903 | 1,770 | 500,000 | SH | Call | OTR | 500,000 | 0 | 0 | |
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 36,863 | 1,966,051 | SH | OTR | 1,966,051 | 0 | 0 | ||
| SOLID BIOSCIENCES INC | COM | 83422E105 | 5,625 | 750,000 | SH | OTR | 750,000 | 0 | 0 | ||
| SUNESIS PHARMACEUTICALS INC | COM PAR | 867328700 | 5,780 | 2,125,000 | SH | OTR | 2,125,000 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 1,423 | 100,000 | SH | OTR | 100,000 | 0 | 0 | ||
| VIKING THERAPEUTICS INC | COM | 92686J106 | 13,923 | 3,186,000 | SH | OTR | 3,186,000 | 0 | 0 | ||
| WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 54,068 | 1,350,000 | SH | OTR | 1,350,000 | 0 | 0 | ||